TBCRC 019: A Phase II Trial of Nanoparticle Albumin-Bound Paclitaxel with or without the Anti-Death Receptor 5 Monoclonal Antibody Tigatuzumab in Patients with Triple-Negative Breast Cancer.
| Image |  |
|---|---|
| Description | scientific article published on 16 March 2015 |
| Author/s |
author: Hope Rugo Minetta C Liu Katherine E Varley William E Grizzle Anna Maria V. Storniolo Nancy U Lin Antonio C. Wolff |
| Publication date | March 16, 2015 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |